Statistics notes: Concealing treatment allocation in randomised trials

British Medical Journal

Volumn 323, Issue 7310, 2001, Pages 446-447

  Altman, D G ^a   Schulz, K F ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b FAMILY HEALTH INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AWARENESS; PATIENT CARE; PATIENT INFORMATION; PRIORITY JOURNAL; RESOURCE ALLOCATION; SHORT SURVEY; STATISTICAL ANALYSIS;

EID: 0035949104     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.323.7310.446     Document Type: Short Survey

References (8)

1. Treatment allocation in controlled trials: Why randomise?
2. How to randomise
3. Subverting randomization in controlled trials
4. Blinding in clinical trials and other studies
5. Streptomycin treatment of pulmonary tuberculosis: A Medical Research Council investigation
6. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses
7. Empirical evidence of bias: Dimensions of methodological quality associated with estimates of treatment effects in controlled trials
8. Improving the quality of reporting of randomized controlled trials: The CONSORT statement